Gene · 406891
Papers2,321
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 2,321
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Tumor-derived systems as novel biomedical tools-turning the enemy into an ally. | Biomater Res | 2023 | 37946275 | PubTator, text mining | PubMed |
| The m6A/m1A/m5C-Related Methylation Modification Patterns and Immune Landscapes in Rheumatoid Arthritis and Osteoarthritis Revealed by Microarray and Single-Cell Transcriptome. | J Inflamm Res | 2023 | 37933335 | PubTator, text mining | PubMed |
| Circulating miR-320b Contributes to CD4+ T-Cell Proliferation in Systemic Lupus Erythematosus via MAP3K1. | J Immunol Res | 2023 | 37928434 | PubTator, text mining | PubMed |
| Cathepsin-facilitated invasion of BMI1-high hepatocellular carcinoma cells drives bile duct tumor thrombi formation. | Nat Commun | 2023 | 37923799 | PubTator, text mining | PubMed |
| Proteomic profiling of urinary extracellular vesicles differentiates breast cancer patients from healthy women. | PLoS One | 2023 | 37922300 | PubTator, text mining | PubMed |
| Association of intestinal dysbiosis with susceptibility to multiple sclerosis: Evidence from different population studies (Review). | Biomed Rep | 2023 | 37901876 | PubTator, text mining | PubMed |
| Oncomeric Profiles of microRNAs as New Therapeutic Targets for Treatment of Ewing's Sarcoma: A Composite Review. | Genes (Basel) | 2023 | 37895198 | PubTator, text mining | PubMed |
| Serum Insights: Leveraging the Power of miRNA Profiling as an Early Diagnostic Tool for Non-Small Cell Lung Cancer. | Cancers (Basel) | 2023 | 37894277 | PubTator, text mining | PubMed |
| Starvation induces changes in abundance and small RNA cargo of extracellular vesicles released from Plasmodium falciparum infected red blood cells. | Sci Rep | 2023 | 37891207 | PubTator, text mining | PubMed |
| Mutant p53 Gain-of-Function Induces Migration and Invasion through Overexpression of miR-182-5p in Cancer Cells. | Cells | 2023 | 37887350 | PubTator, text mining | PubMed |
| Higher expression of PLEK and LY86 as the potential biomarker of carotid atherosclerosis. | Medicine (Baltimore) | 2023 | 37861500 | PubTator, text mining | PubMed |
| Nuclear lncRNA NORSF reduces E2 release in granulosa cells by sponging the endogenous small activating RNA miR-339. | BMC Biol | 2023 | 37858148 | PubTator, text mining | PubMed |
| Deciphering the Functional Long Non-Coding RNAs Derived from MicroRNA Loci. | Adv Sci (Weinh) | 2023 | 37849233 | PubTator, text mining | PubMed |
| The role and impact of alternative polyadenylation and miRNA regulation on the expression of the multidrug resistance-associated protein 1 (MRP-1/ABCC1) in epithelial ovarian cancer. | Sci Rep | 2023 | 37838788 | PubTator, text mining | PubMed |
| Dual mechanism of Let-7i in tumor progression. | Front Oncol | 2023 | 37829341 | PubTator, text mining | PubMed |
| Exploring the role of the inflammasomes on prostate cancer: Interplay with obesity. | Rev Endocr Metab Disord | 2023 | 37819510 | PubTator, text mining | PubMed |
| Brain cell-specific origin of circulating microRNA biomarkers in experimental temporal lobe epilepsy. | Front Mol Neurosci | 2023 | 37808470 | PubTator, text mining | PubMed |
| Analysis of miRNA expression profiles in exosomes of SMB-S15 cells treated with resveratrol. | Arch Virol | 2023 | 37805966 | PubTator, text mining | PubMed |
| Identifying the potential genes in alpha synuclein driving ferroptosis of Parkinson's disease. | Sci Rep | 2023 | 37803093 | PubTator, text mining | PubMed |
| Novel role of immune-related non-coding RNAs as potential biomarkers regulating tumour immunoresponse via MICA/NKG2D pathway. | Biomark Res | 2023 | 37784183 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/406891/papers?page=5